Prescription Practices for Chronic Obstructive Pulmonary Disease: Findings from the National Ambulatory Medical Care Survey 1999–2010
Supporting Files
-
6 2014 ; 6-2014
-
Available in CDC Stacks on 2015-09-03T00:00:00Z
File Language:
English
Details
-
Alternative Title:COPD
-
Personal Author:
-
Description:Recent trends in prescriptions for medicines used to treat chronic obstructive pulmonary disease (COPD) in the United States have received little attention. Our objective was to examine trends in prescribing practices for medications used to treat COPD. We examined data from surveys of national samples of office visits to non-federal employed office-based physicians in the United States by patients aged ≥40 years with COPD recorded by the National Ambulatory Medical Care Survey from 1999 to 2010. From three diagnostic codes, office visits by patients with COPD were identified. Prescribed medications were identified from up to 8 recorded medications. The percentage of these visits during which a prescription for any medication used to treat COPD was issued increased from 27.0% in 1999 to 49.1% in 2010 (p trend < 0.001). Strong increases were noted for short-acting beta-2 agonists (17.6% in 1999 to 24.7% in 2010; p trend < 0.001), long-acting beta-2 agonists as single agents or combination products (6.2% in 1999 to 28.3% in 2010; p trend < 0.001), inhaled corticosteroids as single agents or combination products (10.9% in 1999 to 30.9% in 2010; p trend < 0.001), and tiotropium (3.8% in 2004 to 17.2% in 2010; p trend < 0.001). Since 1999, prescription patterns for medicines used to treat COPD have changed profoundly in the United States.
-
Subjects:
- Administration, Inhalation
- Adrenal Cortex Hormones
- Adrenergic beta-2 Receptor Agonists
- Aged
- Bronchodilator Agents
- Delayed-Action Preparations
- Drug Combinations
- Drug Prescriptions
- Drug Utilization
- Female
- Health Care Surveys
- Humans
- Ipratropium
- Male
- Middle Aged
- Office Visits
- Pulmonary Disease, Chronic Obstructive
- Scopolamine Derivatives
- Tiotropium Bromide
- United States
- Xanthines
-
Keywords:
-
Source:COPD. 11(3):247-255
-
Pubmed ID:24568285
-
Pubmed Central ID:PMC4559259
-
Document Type:
-
Funding:
-
Volume:11
-
Issue:3
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:31cf1cced56cc9d6a2e124a39fcabb984bc9b5535766e0a3dadf8b628b4ff1dcb4a2ed132bd1c9e1a461528b36b39a629418578d34fbbea79fe900dd7ad6bd3e
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access